Follow The Filings

REGN Regeneron

Regeneron earnings company data as of 7:06 PM ET 10/30

  • 1 of 1 EPS beats
  • 2 Owners
  • Rank #178
  • Max 0.9%
  • Master 0.19%

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 30 Oct EPS 12.89 20.07 Beat +55.7%
Rev $4.56B $5.12B Beat +12.1%

Who owns this now

Largest portfolio weights among holders, up to 0.9% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

All holders
  1. Murphy Pohlad Reduce 0.92%

Insider trades

Open-market buys and sales by REGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All REGN insider trades
  • None no insider bought on the open market
  • $281K sold by 1 insider outside a trading plan
  • $11.6M sold by 7 insiders under 10b5-1 plans
  1. Andrew J Murphy Co-Chief Scientific Officer
    Planned sale
    $3.2M 4,147 shares at $772.70 8% of stake
    Traded Oct 14 Filed Oct 15
    ↗
  2. Kathryn Guarini Director
    Planned sale
    $340K 400 shares at $850.00 40% of stake
    Traded Sep 2 Filed Sep 3
    ↗
  3. Marion McCourt EVP Commercial
    Planned sale
    $2M 2,346 shares at $853.56 16% of stake
    Traded Sep 2–3 Filed Sep 3
    ↗
  4. Kathryn Guarini Director
    Planned sale
    $320K 400 shares at $800.00 40% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  5. Huda Y Zoghbi Director
    Planned sale
    $640K 800 shares at $800.00 32% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  6. Arthur F Ryan Director
    Planned sale
    $130K 200 shares at $650.15 1.1% of stake
    Traded Jul 2 Filed Jul 7
    ↗
  7. Arthur F Ryan Director
    Planned sale
    $71K 100 shares at $705.24 0.6% of stake
    Traded May 1 Filed May 4
    ↗
  8. Arthur F Ryan Director
    Planned sale
    $78K 100 shares at $777.27 0.6% of stake
    Traded Apr 1 Filed Apr 3
    ↗
  9. Arthur F Ryan Director
    Planned sale
    $79K 100 shares at $785.50 0.6% of stake
    Traded Mar 2 Filed Mar 3
    ↗
  10. Huda Y Zoghbi Director
    Planned sale
    $1.3M 1,638 shares at $781.33 49% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  11. Jason Pitofsky SVP Controller
    Planned sale
    $1.6M 2,036 shares at $778.52 32% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  12. Arthur F Ryan Director
    Planned sale
    $78K 100 shares at $778.53 0.6% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  13. Bonnie L Bassler Director
    Planned sale
    $1.2M 1,500 shares at $800.00 47% of stake
    Traded Jan 7 Filed Jan 8
    ↗
  14. Bonnie L Bassler Director
    Planned sale
    $570K 760 shares at $750.00 33% of stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
    ↗
  15. Jason Pitofsky VP Controller
    Sale
    $281K 431 shares at $651.43 9.2% of stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 share withholdings for taxes, 17 stock grants, and 16 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,2.02,8.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
8-K 2.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 20 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.